|
|
| Aga Khan University Hospital, Nairobi, Kenya |
| |
| IMPROVING QUALITY, PATIENT CARE & EXPERIENCE, WHILE LOWERING COSTS THROUGH ENHANCED LABORATORY STEWARDSHIP |
| Cleveland Clinic, Cleveland, Ohio, USA |
| |
| NOVEL COLLABORATIVE APPROACH AMONG PUBLIC AND PRIVATE SECTORS FOR STREAMLINED SARS-COV-2 TESTING TOWARDS OPTIMIZED PATIENT OUTCOME DURING COVID-19 PANDEMIC |
| Dubai Health Authority, Dubai, United Arab Emirates |
| |
| IMPROVING ACCESS TO HEALTH SERVICES IN VULNERABLE COMMUNITIES AFFECTED BY WAR |
| Esculab, Lviv, Ukraine |
| |
| IMPROVED SAFETY FOR PATIENTS WITH INDETERMINANT PULMONARY NODULES THROUGH OPTIMIZED DIAGNOSTIC PATHWAYS FOR LUNG CANCER |
| The First Affiliated Hospital of Sun Yat-sen University, Guangdong, China |
| |
| IDENTIFYING UNTREATED HEPATITIS B AND HEPATITIS C VIA OPT-OUT SCREENING PROGRAM IN URBAN ED SETTINGS |
| Guy's and St Thomas’ NHS Foundation Trust and Viapath Pathology Analytics, London, England |
| |
| THE GLOBAL IMPACT OF TROPONIN AND BIOMARKERS ON ISCHEMIC MYOCARDIAL INJURY AND SURGICAL CARE |
| Hamilton Health Sciences/Population Health Research Institute, Hamilton, Canada |
| |
| EARLY DETECTION AND MANAGEMENT OF GESTATIONAL DIABETES MELLITUS FOR IMPROVED OUTCOMES OF MOTHERS AND THEIR BABIES |
| Hospital Clinico San Carlos, Madrid, Spain |
| |
| REDUCING CATASTROPHIC ADVERSE EVENTS IN PATIENTS WITH HEMORRHAGIC SHOCK THROUGH EARLY RECOGNITION OF RISK AND SYSTEM-WIDE AUTOMATIC ALERTS |
| Hospital Israelita Albert Einstein, São Paulo, Brazil |
| |
| REDUCING POST-OPERATIVE COMPLICATIONS IN CARDIAC SURGERY PATIENTS |
| Hospital Virgen Macarena, Sevilla, Spain |
| |
| REDUCED HEPATOCELLULAR CARCINOMA RECURRENCE WITH ENHANCED 3-YEAR SURVIVAL FOR PATIENTS POST LIVER TRANSPLANT |
| Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan |
| |
|
|
| King Abdulaziz Medical City, Jeddah, Saudi Arabia |
| |
| THE FIIX PROJECT: REDUCING ANTICOAGULATION VARIABILITY AND ADVERSE PATIENT OUTCOMES THROUGH SAFE AND COST-EFFECTIVE FACTOR II AND X (FIIX) MONITORING IN PLACE OF CONVENTIONAL PT-INR WARFARIN MONITORING |
| Landspitali National University Hospital of Iceland Reykjavik, Iceland |
| |
|
|
| Marienhospital, Stuttgart, Germany |
| |
| PREVENTING CARDIOVASCULAR DISEASE IN A LARGE CLIENT POPULATION THROUGH PROACTIVE, COST-EFFECTIVE AND ENHANCED IDENTIFICAITON OF CARDIOVASCULAR RISK USING A NOVEL LABORATORY TEST |
| Medcan Health Management Inc., Toronto, Canada |
| |
| ENHANCED RESOURCE UTILIZATION, REDUCED WASTE, AND EXPEDITED TRANSPLANTATION THROUGH REAL-TIME DONOR SCREENING FOR INFECTIOUS DISEASE |
| Mid America Transplant, St. Louis, Missouri, USA |
| |
| EARLY DIAGNOSIS OF MATERNAL CYTOMEGALOVIRUS FOR IMPROVED MANAGEMENT AND REDUCED RISK OF FETAL TRANSMISSION AND COMPLICATIONS |
| National Reference Center for Herpesvirus, University Hospital Center, Limoges, France |
| |
| USE OF FECAL IMMUNOCHEMICAL TESTS (FIT) UNLOCKS THE DOOR TO EFFICIENT AND EFFECTIVE INVESTIGATION OF PATIENTS WITH NEW BOWEL SYMPTOMS |
| NHS Tayside, Dundee, Scotland |
| |
| REDUCTION OF INPATIENT DAILY BLOOD DRAWS WITH DATA SCIENCE AND CLINICAL COLLABORATION |
| St. Paul’s Hospital, Vancouver, Canada |
| |
| FH ALERT: IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH) BY USING THE EXPERTISE AND RESOURCES OF THE CLINICAL LABORATORY |
| SYNLAB Holding Deutschland GmbH, Munich, Germany |
| |
| IMPLEMENTATION OF A COMPREHENSIVE SYPHILIS SCREENING STRATEGY FOR COST-EFFECTIVE AND TIMELY SYPHILIS MANAGEMENT |
| Tongji Hospital, Tongji Medical College, and Huazhong University of Science and Technology, Hubei, Mainland China |
| |
| IMPROVING CLINICAL AND QUALITY OUTCOMES FOR PRENATAL CARE – A CLINICAL LABORATORY DRIVEN INITIATIVE |
| TriCore Reference Laboratories, Albuquerque, New Mexico, USA |
| |
| ADDRESSING COVID CLINICAL AND TRANSLATIONAL CHALLENGES VIA MULITDISCIPLINE INTEGRATED DIAGNOSTICS NETWORKS |
| University Hospital Coventry and Warwickshire NHS Trust & Warwick Medical School, Coventry, England |
| |
| IMPROVED PATIENT OUTCOMES FACILITATED BY C-PEPTIDE TESTING, ENABLING RECLASSIFICATION AND THERAPEUTIC CHANGES FOR PATIENTS WITH DIABETES |
| University Hospital of Wales, Cardiff, Wales |
| |
| GETTING TO ZERO HARM IN CONTROLLED SUBSTANCE PRESCRIBING: INCREASING THE ACCURACY OF PRESCRIPTION COMPLIANCE MONITORING THROUGH ENHANCED DRUG TESTING SUPPORT |
| University Hospitals Cleveland, Cleveland, Ohio, USA |
| |
| OPTIMIZATION OF HEART FAILURE MANAGEMENT USING BIOMARKERS IN PATIENTS WITH LOW RISK FOR REHOSPITALIZATION |
| University Medical Center, Groningen, Netherlands |
| |
| ENHANCED IDENTIFICATION AND CARE FOR PATIENTS WITH UNDETECTED HCV AND/OR HIV VIA OPT-OUT ED SCREENING WITH ACTIVE EDUCATION AND LINKAGE TO CARE |
| University of Alabama-Birmingham Hospital, Birmingham, Alabama, USA |
| |
| IMPROVING EQUITY IN MATERNAL AND NEWBORN OUTCOMES BY ELIMINATING DISPARITIES IN MATERNAL DRUG SCREENING |
| Washington University School of Medicine, Barnes-Jewish Hospital, and St. Louis Children's Hospital, St. Louis, Missouri, USA |
.jpg)
